NYSE · Analyst Forecast

Enovis Corporation (ENOV) Stock Forecast & Price Target

$27.22 NYSE: ENOV Market Cap $1.57B

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 17, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Enovis Corporation (ENOV), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Enovis Corporation, analysts forecast revenue rising from $2.10B in 2024 to $2.75B in 2029; the average estimate for 2029 earnings per share is $4.57; with published estimates ranging from $4.53 to $4.60; 9 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$27.22
Consensus targetThe average of the price targets analysts have published.$37.33
Median targetThe middle target, less affected by a single outlier.$38.00
Highest targetThe most optimistic published target.$45.00
Lowest targetThe most pessimistic published target.$27.00
Difference from priceHow far the consensus target sits from today’s price.+37.1%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2024$2.09B$2.10B$2.11B7
2025$2.24B$2.26B$2.27B7
2026$2.32B$2.34B$2.35B9
2027$2.43B$2.45B$2.46B9
2028$2.53B$2.56B$2.58B8
2029$2.73B$2.75B$2.76B6

Earnings per share forecast

YearLowAverageHighAnalysts
2024$2.77$2.78$2.797
2025$3.17$3.20$3.227
2026$3.68$3.70$3.719
2027$3.05$3.46$3.889
2028−$2.25$3.81$12.228
2029$4.53$4.57$4.606

Enovis Corporation (ENOV) forecast — frequently asked questions

What is the analyst price target for Enovis Corporation?

Analysts covering Enovis Corporation (ENOV) have a consensus price target of $37.33, 37.1% above the current price of $27.22. Published targets range from $27.00 to $45.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Enovis Corporation's earnings?

The average analyst estimate for Enovis Corporation (ENOV) earnings per share in 2029 is 4.57, with individual estimates between 4.53 and 4.60.

How much revenue is Enovis Corporation expected to make?

Analysts forecast Enovis Corporation (ENOV) revenue of $2.75B in 2029, based on 6 published estimates.

How many analysts cover ENOV?

9 analysts contribute estimates for Enovis Corporation (ENOV). Thin coverage makes an average less reliable.

Analyst forecasts for other Medical - Devices stocks

ABT forecastISRG forecastMDT forecastSYK forecastBSX forecastEW forecastRMD forecastDXCM forecastPHG forecastZBH forecastAll Medical - Devices stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.